GIUSTI, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 11.906
Totale 11.906
Nazione #
IT - Italia 11.906
Totale 11.906
Città #
Genova 9.149
Rapallo 1.327
Genoa 1.076
Vado Ligure 328
Bordighera 26
Totale 11.906
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 293
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 171
Characteristics of a nationwide cohort of patients presenting with Isolated Hypogonadotropic Hypogonadism (IHH) 149
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 144
Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease 138
The pathology of the ulnar nerve in acromegaly. 137
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma 136
Ten-year estimated risk of bone fracture in women with differentiated thyroid cancer under TSH-suppressive levothyroxine therapy 135
Detection of Polyethylene Glycol Thyrotropin (TSH) Precipitable Percentage (Macro-TSH) in Patients with a History of Thyroid Cancer 134
A case of thyroid cancer on the track of the radiofrequency electrode 30 months after percutaneous ablation 133
Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and border-line value of the hormone 132
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration 131
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 131
Cell specific interaction of pasireotide: review of preclinical studies in somatotroph and corticotroph pituitary cells 131
A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid. 130
Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm. 130
Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR 128
Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. 127
Increasing hirsutism due to a granulosa-cell tumor in a woman with polycystic ovary syndrome: case report and review of the literature. 126
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 126
Evaluation of adequacy of levo-thyroxine dosage in patients with differentiated thyroid carcinoma: correlation between morning and afternoon TSH determination 125
Circulating nitric oxide in women affected by weight loss amenorrhea during pulsatile gonadotropin-releasing hormone therapy 124
Nitric oxide modulates in vivo and in vitro growth hormone release in acromegaly. 124
Growth-hormone, prolactin and cortisol nyctohemeral variations during naloxone-induced opiate receptor blockade in man. 122
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 122
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. 122
Quality of Life in Patients Treated with Percutaneous Laser Ablation for Non-Functioning Benign Thyroid Nodules: A Prospective Single-Center Study 122
Treatment of a pituitary metastasis from a neuroendocrine tumour: case report and literature review. 118
An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma 118
Morphine-induced TSH release in normal and hypothyroid subjects. 117
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 117
Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients 117
Sympathovagal imbalance in acromegalic patients 116
Parathyroid autotransplantation. 115
Androgen replacement therapy in male patients with rheumatoid arthritis. 115
Slow-release lanreotide and octreotide LAR in the medical therapy of acromegaly. 114
Simple dietary advice reduces 24-hour urinary sodium excretion, blood pressure, and drug consumption in hypertensive patients 114
Increased prevalence of Helicobacter pylori infection in females treated with dopaminergic drugs for hyperprolactinaemia. 113
Low-Salt Intake Suggestions in Hypertensive Patients Do not Jeopardize Urinary Iodine Excretion 113
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma 113
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 112
Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer 112
A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis 111
Institutional experience of PTH evaluation on fine-needle washing after aspiration biopsy to locate hyperfunctioning parathyroid tissue. 110
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 110
In memory of Francesco Maria Minuto. 110
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 109
A unique association of clinical "persistent müllerian duct syndrome" and syringoid carcinoma of the perineal-scrotal skin: a consequence of urologic surgery? 109
Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man. 108
Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients 108
Prolactin decrease and shift to a normal-like isoform profile during treatment with quinagolide in a patient affected by an invasive prolactinoma. 107
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy. 107
Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing 107
Primary hyperparathyroidism in pregnancy treated with cinacalcet: A case report and review of the literature 107
Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center 106
Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system 105
A case of thyroiditis during natalizumab therapy for multiple sclerosis 105
Benign thyroid nodule unresponsive to radiofrequency ablation treated with laser ablation: a case report 105
Can baseline endocrinological examination and thyroid ultrasound predict the development of thyroid disease in immunotherapy-treated patients? Results from a prospective, single-center, open-label study 105
Retrospective cytological evaluation of indeterminate thyroid nodules according to the British Thyroid Association 2014 classification and comparison of clinical evaluation and outcomes 104
Role of Strain Elastography and Shear-Wave Elastography in a Multiparametric Clinical Approach to Indeterminate Cytology Thyroid Nodules 103
Evaluation of Quality of Life in Patients with Differentiated Thyroid Cancer by Means of the Thyroid-Specific Patient-Reported Outcome Questionnaire: A 5-Year Longitudinal Study 103
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 100
Is there a real diagnostic impact of elastosonography and contrast-enhanced ultrasonography in the management of thyroid nodules? 100
Metabolic and cardiovascular risk in patients with a history of differentiated thyroid carcinoma: A case-controlled cohort study 99
Ranitidine and testosterone secretion in man. 99
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 98
Androgen status in postmenopausal patients with rheumatoid arthritis. 98
A. novel mechanism for the melatonin inhibition of testosterone secretion by rat Leydig cells: reduction of GnRH-induced cytosolic Ca2+ rise 98
Desmopressin and low-dose ACTH test in rheumatoid arthritis. 97
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogs and dopastatins 96
Replacement therapy and cardiovascular diseases 96
Desmopressin, ovine CRH, and low-dose ACTH tests: tools for the study of the hypothalamic-pituitary-adrenal axis in premenopausal rheumatoid arthritis patients. 96
Cost-of-illness study in acromegalic patients in Italy 96
Epidemiology of acromegaly in Italy: analysis from a large longitudinal primary care database 96
Testosterone metabolism and cyclosporin A treatment in rheumatoid arthritis. 94
Papillary thyroid cancer in a struma ovarii: a report of a rare case 94
Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly. 92
Current diagnostic guidelines for biochemical diagnosis of acromegaly. 88
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. 87
Cabergoline modulation of alpha-subunits and FSH secretion in a gonadotroph adenoma 87
Preliminary results of serum androgen level testing in men with rheumatoid arthritis. 86
Five-year longitudinal evaluation of quality of life in a chort of patients with different thyroid carcinoma 86
Effects of melatonin on interleukin – 12 and nitric oxide production by cultured synovial macrophages in rheumatoid arthritis 85
Altered stress response of adrenal steroids in premenopausal rheumatoid arthritis patients 85
Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. 84
Desmopressin, ovineCRH and low-dose ACTH tests: tools for the study of hypotalamus- pituitary-adrenal axis in premenopausal rheumatoid arthritis patients 84
Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan. 83
In vitro effect of human recombinant leptin and expression of leptin receptors on growth hormone-secreting human pituitary adenomas 82
CYP17 polymorphisms and androgen levels in postmenopausal patients with rheumatoid arthritis. 80
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 79
Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency. 78
Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma 78
PTH radioimmunoassay and loading tests in the diagnosis of patients with primary hyperparathyroidism. 78
A very low vitamin D threshold, within the range of severe deficiency, identifies an increased risk of non-classical vitamin D-related outcomes in medical inpatients: a role for parathyroid hormone? 74
The hypothalamic-pituitary-adrenal and gonadal axes in rheumatoid arthritis. 74
Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: six-month report on an Italian multicenter study. Italian Multicenter Slow Release Lanreotide Study Group. 74
Somatostatin and its analog lanreotide inhibit the proliferation of dispersed human non-functioning pituitary adenoma cells in vitro 73
Prulifloxacin vs Levofloxacin for Exacerbation of COPD after Failure of Other Antibiotics 72
Papillary carcinoma in struma ovarii: A case report 69
Totale 10.901
Categoria #
all - tutte 32.962
article - articoli 32.260
book - libri 0
conference - conferenze 702
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.186 0 0 0 233 336 419 546 235 362 555 364 136
2020/20211.050 58 96 127 63 67 101 75 113 93 100 74 83
2021/20221.447 53 78 113 183 72 108 81 296 105 142 61 155
2022/20231.563 143 113 24 156 335 250 11 108 233 6 168 16
2023/2024821 41 95 6 108 75 146 54 36 43 37 67 113
2024/2025379 84 164 116 15 0 0 0 0 0 0 0 0
Totale 12.057